iStent inject approval tops recent glaucoma news

Glaucoma news in recent months as reported on Healio.com/OSN has included FDA approvals, study results and video perspectives from meetings.
Here are some of the latest most-read articles and most-watched videos:
 
FDA approves iStent inject
The iStent inject trabecular micro-bypass system has received premarket approval from the FDA for the reduction of IOP. Read more.
 
Bimatoprost sustained-release implant shows positive phase 3 data
A bimatoprost sustained-release implant reduced IOP by approximately 30% over 12 weeks in a phase 3 clinical study. Read more.
 
VIDEO: Rhopressa works

Full Story →